Actos & Congestive Heart Failure

Free Case Evaluation

The antihyperglycemic drug, Actos, is involved with a number of lawsuits concerning Actos congestive heart failure. Actos is a thiazolidinedione (TZD) used to control blood sugar levels in patients with type 2 diabetes. Actos congestive heart failure is only one of the potentially serious heart complications experienced by patients. It is because of Actos congestive heart failure and these other serious health risks that Actos was issued a “black box warning” from the Food and Drug Administration (FDA).

Actos Black Box Warning

The black box warning, or black label warning, is the most serious advisory that is issued by the FDA for any medication. It is a warning to doctors and patients that the drug could have potentially fatal effects in high risk patients.

For Actos, this is a warning about Actos congestive heart failure as well as other conditions related to heart failure. Patients with a history of heart problems, especially heart failure, are advised to avoid the use of Actos for treating their type 2 diabetes symptoms.

Symptoms of Actos Congestive Heart Failure

Actos congestive heart failure is a heart condition where the heart is unable to adequately pump blood through the system. The term “failure” does not necessarily mean that the heart has stopped functioning, but that it does not function properly. The term actually refers to the amount of blood volume that is capable of being pumped throughout the system.

Some symptoms of Actos congestive heart failure:

  • Inability to breathe/shortness of breath (dyspnea)
  • Chronic coughing
  • Wheezing
  • Fatigue
  • Rapid/irregular heartbeat
  • Mental confusion
  • Fluid build up
  • Nausea or lack of appetite

The main reasons that Actos congestive heart failure may occur is either from weak, stiff heart muscles or that bodily tissues at specific parts of the body require an increased amount of blood flow. If the body is incapable of meeting the needs for increased blood flow in the body then symptoms of Actos congestive heart failure may begin to occur.

Another aspect of Actos congestive heart failure is edema, or fluid retention, in parts of the body. Edema can occur is several parts of the body. If edema occurs in the lungs this is called pulmonary edema. Edema can also occur in other organs like the liver or in areas like a person’s arms or legs. It will become more difficult for a person to physically exert themselves if they begin to develop edema in any part of their body.

Actos Congestive Heart Failure Lawsuits

Actos has been on the market since the late 1990s. It has currently been prescribed to millions of type 2 diabetes patients. While it is effective in dealing with blood sugar problems in patients, it has also been shown to carry the risk of potentially life-threatening conditions to its users.

Among the problems associated with Actos are heart failure, bladder cancer, lactic acidosis, macular edema, and bone fractures. Since the medication has a risk of causing these serious problems for patients, lawsuits were filed in attempt to earn the patients medical compensation.

Bladder cancer is the leading reason for Actos lawsuits. However, Actos congestive heart failure is another common reason for filing suit against the manufacturers. More than 3,000 patients have filed suit against the drug manufacturers from developing bladder cancer. Studies have shown that there is an 83 percent increased risk of developing bladder cancer. Likewise, Actos congestive heart failure is a substantial risk in patients and is also a frequent subject of lawsuit.

Patients may be eligible for compensation for Actos congestive heart failure from the drug manufacturers, Takeda, since they had failed to mention the risk of serious health complications despite having information regarding the matters. This oversight in patient safety has cost the well-being of millions of patients around the country.

View Sources

  1. “Heart Failure Signs and Symptoms.” University of California San Francisco Medical Center. n. page. Web. 25 Apr. 2013.
  2. “Heart failure – overview.” MedlinePlus. N.p.. Web. 25 Apr 2013.
  3. Singh, Sonal, Yoon Loke, and Curt Furberg. “Thiazolidinediones and Heart Failure: A Teleo-Analysis.” American Diabetes Association. (2007): n. page. Web. 25 Apr. 2013.
  4. “WARNING: CONGESTIVE HEART FAILURE.”DailyMed. N.p., n.d. Web. 25 Apr 2013.
Have you been affected by a drug or device listed? Call 1-888-537-3057